title: Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply.
authors.affiliation: University Hospitals of Geneva, Geneva, Switzerland. Electronic address: cem.gabay@hcuge.ch.
authors.forename: Cem
authors.initials: C
authors.lastname: Gabay
authors.affiliation: University of California, San Diego, La Jolla, CA, USA.
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents